Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
|
|
Asterias Biotherapeutics, Inc. (AST)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/12/2019 |
4
| BROADWOOD PARTNERS, L.P. (See Remarks Below) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Disposed of 5,292,156 shares
@ $0 |
|
| 03/05/2019 |
4
| Wirth Edward (Chief Medical Officer) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 156,452 shares
@ $0
Paid exercise price by delivering 48,826 shares
@ $0.95, valued at
$46.4k
|
|
| 03/05/2019 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 252,606 shares
@ $0
Paid exercise price by delivering 76,588 shares
@ $0.95, valued at
$72.8k
|
|
| 03/05/2019 |
4
| Chavez Ryan Daniel (CFO and General Counsel) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 145,263 shares
@ $0
Paid exercise price by delivering 44,471 shares
@ $0.95, valued at
$42.2k
|
|
| 01/04/2019 |
4
| Chavez Ryan Daniel (CFO and General Counsel) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Paid exercise price by delivering 20,440 shares
@ $0.68, valued at
$13.9k
|
|
| 01/04/2019 |
4
| Wirth Edward (Chief Medical Officer) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Paid exercise price by delivering 20,440 shares
@ $0.68, valued at
$13.9k
|
|
| 08/29/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 3,141 shares
@ $1.5918, valued at
$5k
|
|
| 07/27/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 2,950 shares
@ $1.6949, valued at
$5k
|
|
| 06/27/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 3,067 shares
@ $1.63, valued at
$5k
|
|
| 06/25/2018 |
4
| Scher Howard Isador (Director) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $1.75, valued at
$35k
|
|
| 06/25/2018 |
4
| RICCIARDI NATALE S (Director) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $1.75, valued at
$35k
|
|
| 06/25/2018 |
4
| LeBuhn Richard T. (Director) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $1.75, valued at
$35k
|
|
| 06/25/2018 |
4
| Cartt Stephen LaHue (Director) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $1.75, valued at
$35k
|
|
| 06/25/2018 |
4
| BAILEY DON M (Director) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 75,000 options
@ $1.75, valued at
$131.3k
|
|
| 06/25/2018 |
4
| Arno Andrew (Director) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $1.75, valued at
$35k
|
|
| 05/31/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 3,153 shares
@ $1.5857, valued at
$5k
|
|
| 04/27/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 3,752 shares
@ $1.33, valued at
$5k
|
|
| 03/30/2018 |
4
| Wirth Edward (Chief Medical Officer) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Paid exercise price by delivering 6,483 shares
@ $1.45, valued at
$9.4k
|
|
| 03/30/2018 |
4
| Chavez Ryan Daniel (CFO and General Counsel) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Paid exercise price by delivering 6,483 shares
@ $1.45, valued at
$9.4k
|
|
| 03/28/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 2,839 shares
@ $1.76, valued at
$5k
|
|
| 03/19/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 94,872 shares
@ $0
Paid exercise price by delivering 28,358 shares
@ $1.95, valued at
$55.3k
Granted 200,000 options
@ $1.95, valued at
$390k
|
|
| 03/19/2018 |
4
| Wirth Edward (Chief Medical Officer) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 50,000 shares
@ $0
Granted 74,000 shares
@ $0
Paid exercise price by delivering 22,686 shares
@ $1.95, valued at
$44.2k
Granted 150,000 options
@ $1.95, valued at
$292.5k
|
|
| 03/19/2018 |
4
| Chavez Ryan Daniel (CFO and General Counsel) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 50,000 shares
@ $0
Granted 68,708 shares
@ $0
Paid exercise price by delivering 21,633 shares
@ $1.95, valued at
$42.2k
Granted 150,000 options
@ $1.95, valued at
$292.5k
|
|
| 02/28/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 2,255 shares
@ $2.2172, valued at
$5k
|
|
| 01/26/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 2,134 shares
@ $2.343, valued at
$5k
|
|
| 12/28/2017 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 2,247 shares
@ $2.22, valued at
$5k
|
|
| 11/29/2017 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 2,076 shares
@ $2.41, valued at
$5k
|
|
| 10/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/28/2017 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 800,000 options to buy
@ $3.7, valued at
$3M
|
|
| 06/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|